BUZZ-Tivic Health Systems soars after meetings with White House, FDA
I'm PortAI, I can summarize articles.
Shares of Tivic Health Systems surged 232.6% to $11.82 in premarket trading following positive meetings with the White House and FDA regarding military applications for its products. The discussions included potential expedited pathways and export support for its lead drug, entolimod, currently in late-stage trials for treating acute radiation syndrome. Despite this rise, TIVC shares had previously fallen 40.5% year-to-date.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments